Destruction of tumor vasculature and abated tumor growth upon VEGF blockade is driven by proapoptotic protein Bim in endothelial cells
Open accessThe DOI matches its Crossref record; 28 of the 29 references it cites were found in a registry or an index.
Abstract
For malignant growth, solid cancers must stimulate the formation of new blood vessels by producing vascular endothelial growth factor (VEGF-A), which is required for the survival of tumor-associated vessels. Novel anticancer agents that block VEGF-A signaling trigger endothelial cell (EC) apoptosis and vascular regression preferentially within tumors, but how the ECs die is not understood. In this study, we demonstrate that VEGF-A deprivation, provoked either by drug-induced tumor shrinkage or direct VEGF-A blockade, up-regulates the proapoptotic BH3 (Bcl-2 homology 3)-only Bcl-2 family member Bim in ECs. Importantly, the tumor growth inhibitory activity of a VEGF-A antagonist required Bim-induced apoptosis of ECs. These findings thus reveal the mechanism by which VEGF-A blockade induces EC apoptosis and impairs tumor growth. They also indicate that drugs mimicking BH3-only proteins may be exploited to kill tumor cells not only directly but also indirectly by ablating the tumor vasculature.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“BIM polymorphisms that decrease BIM expression are well known to cause patient resistance to many conventional cancer treatments including anti-VEGF [26–28].”
From Thrombospondin-1, BIM and CFH polymorphisms and response to anti-VEGF treatment in neovascular age- related macular degeneration patients (2024) · cites this paper as [26]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The BCL-2 protein family: opposing activities that mediate cell death
Youle, R. J., & Strasser, A. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2308 · Cited by 4,679 · cited 4×
“Because the prosurvival protein Bcl-2 is up-regulated in ECs after stimulation with VEGF (Gerber et al., 1998), we reasoned that a proapoptotic BH3 (Bcl-2 homology 3)-only member of that family (Youle and Strasser, 2008) might initiate the EC death provoked by falling VEGF levels when solid tumors…”
BackgroundInfluentialSelf-citationTumorigenesis and the angiogenic switch
Bergers, G., & Benjamin, L. E. (2003) · Nature reviews. Cancer · doi:10.1038/nrc1093 · Cited by 3,559
An inhibitor of Bcl-2 family proteins induces regression of solid tumours
Oltersdorf, T., Elmore, S. W., Shoemaker, A. R., Armstrong, R. C., Augeri, D. J., Belli, B. A., Bruncko, M., Deckwerth, T. L., Dinges, J., Hajduk, P. J., et al. (2005) · Nature · doi:10.1038/nature03579 · Cited by 3,416
Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer
Ferrara, N., Hillan, K. J., Gerber, H.-P., & Novotny, W. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1381 · Cited by 2,625 · cited 1×
“Because the prosurvival protein Bcl-2 is up-regulated in ECs after stimulation with VEGF (Gerber et al., 1998), we reasoned that a proapoptotic BH3 (Bcl-2 homology 3)-only member of that family (Youle and Strasser, 2008) might initiate the EC death provoked by falling VEGF levels when solid tumors…”
BackgroundVEGF-targeted therapy: mechanisms of anti-tumour activity
Ellis, L. M., & Hicklin, D. J. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2403 · Cited by 1,673
Guy, C. T., Cardiff, R. D., & Muller, W. J. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.3.954 · Cited by 1,631
Bouillet, P., Metcalf, D., Huang, D. C. S., Tarlinton, D. M., Kay, T. W. H., Köntgen, F., Adams, J. M., & Strasser, A. (1999) · Science · doi:10.1126/science.286.5445.1735 · Cited by 1,504 · cited 6×
“The BH3-only protein Bim (O’Connor et al., 1998) is critical for the apoptosis induced by cytokine deprivation in several cell types (Bouillet et al., 1999; Youle and Strasser, 2008), and notably, in early development of the eye, Bim is critical for the programmed cell death of the ECs comprising…”
BackgroundMethodInfluentialSelf-citationp53- and Drug-Induced Apoptotic Responses Mediated by BH3-Only Proteins Puma and Noxa
Villunger, A., Michalak, E. M., Coultas, L., Müllauer, F., Böck, G., Ausserlechner, M. J., Adams, J. M., & Strasser, A. (2003) · Science · doi:10.1126/science.1090072 · Cited by 1,327
Self-citationBim: a novel member of the Bcl-2 family that promotes apoptosis
O'Connor, L. (1998) · The EMBO Journal · doi:10.1093/emboj/17.2.384 · Cited by 1,166
Self-citationGerber, H.-P., Dixit, V., & Ferrara, N. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.21.13313 · Cited by 981 · cited 2×
“Because the prosurvival protein Bcl-2 is up-regulated in ECs after stimulation with VEGF (Gerber et al., 1998), we reasoned that a proapoptotic BH3 (Bcl-2 homology 3)-only member of that family (Youle and Strasser, 2008) might initiate the EC death provoked by falling VEGF levels when solid tumors…”
BackgroundDijkers, P. F., Medema†, R. H., Lammers, J.-W. J., Koenderman, L., & Coffer, P. J. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00728-4 · Cited by 976 · cited 1×
“S5 D) is consistent with the activation and nuclear translocation of this transcription factor, which induces Bim transcription after cytokine withdrawal (Dijkers et al., 2000).”
BackgroundThe vascular endothelial growth factor family of polypeptides
Ferrara, N., Houck, K. A., Jakeman, L. B., Winer, J., & Leung, D. W. (1991) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240470305 · Cited by 641 · cited 2×
“Vol. 208 No. 7 1351-1358 www.jem.org/cgi/doi/10.1084/jem.20100951 1351 Br ief Definit ive Repor t To expand substantially and spread malignantly, a cancer must induce the formation of new blood vessels (Bergers and Benjamin, 2003; Ferrara et al., 2004).”
BackgroundInfluentialEndostatin Induces Endothelial Cell Apoptosis
Dhanabal, M., Ramchandran, R., Waterman, M. J. F., Lu, H., Knebelmann, B., Segal, M., & Sukhatme, V. P. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.17.11721 · Cited by 584 · cited 1×
“Diverse treatment modalities provoke EC apoptosis in solid tumors (Dhanabal et al., 1999; Park et al., 2005); thus, polymorphisms in genes that control EC apoptosis, such as BIM or its regulators, may affect the therapeutic responses of cancer patients.”
BackgroundRedefining the Target: Chemotherapeutics as Antiangiogenics
Miller, K. D., Sweeney, C. J., & Sledge, G. W. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.4.1195 · Cited by 395 · cited 1×
“The BH3-only protein Bim (O’Connor et al., 1998) is critical for the apoptosis induced by cytokine deprivation in several cell types (Bouillet et al., 1999; Youle and Strasser, 2008), and notably, in early development of the eye, Bim is critical for the programmed cell death of the ECs comprising…”
BackgroundLiang, W.-C., Wu, X., Peale, F. V., Lee, C. V., Meng, Y. G., Gutierrez, J., Fu, L., Malik, A. K., Gerber, H.-P., Ferrara, N., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m508199200 · Cited by 346 · cited 1×
“However, conventional anticancer drugs can complicate studies of the relationship between the tumor and its vasculature by directly killing the ECs (Miller et al., 2001).”
BackgroundCragg, M. S., Kuroda, J., Puthalakath, H., Huang, D. C. S., & Strasser, A. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040316 · Cited by 343
Self-citationRegulatory phosphorylation of Bim: sorting out the ERK from the JNK
Ley, R., Ewings, K. E., Hadfield, K., & Cook, S. J. (2005) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401688 · Cited by 313
Intra-tumoural microvessel density in human solid tumours
Hasan, J., Byers, R., & Jayson, G. C. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600315 · Cited by 308 · cited 2×
“The generation of Bim/ mice (Bouillet et al., 1999), now backcrossed for >20 generations onto a C57BL/6 genetic background, and Bmf/ (Labi et al., 2008), Puma/ (Villunger et al., 2003), and Bid/ (Kaufmann et al., 2007) mice, all generated on an inbred C57BL/6 background using C57BL/6-derived embryonic stem cells, has…”
MethodDegenerative Disorders Caused by Bcl-2 Deficiency Prevented by Loss of Its BH3-Only Antagonist Bim
Bouillet, P., Cory, S., Zhang, L.-C., Strasser, A., & Adams, J. M. (2001) · Developmental Cell · doi:10.1016/s1534-5807(01)00083-1 · Cited by 274 · cited 2×
“To monitor Bim expression in tumor-associated ECs, we exploited Bim-lacZ (heterozygous) knockin mice, in which a -galactosidase transcriptional reporter replaces the Bim coding region (Bouillet et al., 2001).”
BackgroundSelf-citationO’Reilly, L. A., Cullen, L., Visvader, J., Lindeman, G. J., Print, C., Bath, M. L., Huang, D. C. S., & Strasser, A. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64557-9 · Cited by 235
Self-citationCragg, M. S., Jansen, E. S., Cook, M., Harris, C., Strasser, A., & Scott, C. L. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35437 · Cited by 207 · cited 1×
“Pertinently, small molecule mimetics of BH3-only proteins, such as ABT-737, have shown efficacy in preclinical solid tumor models (Oltersdorf et al., 2005; Cragg et al., 2007, 2008).”
BackgroundSelf-citationKaufmann, T., Tai, L., Ekert, P. G., Huang, D. C. S., Norris, F., Lindemann, R. K., Johnstone, R. W., Dixit, V. M., & Strasser, A. (2007) · Cell · doi:10.1016/j.cell.2007.03.017 · Cited by 206 · cited 2×
“The generation of Bim/ mice (Bouillet et al., 1999), now backcrossed for >20 generations onto a C57BL/6 genetic background, and Bmf/ (Labi et al., 2008), Puma/ (Villunger et al., 2003), and Bid/ (Kaufmann et al., 2007) mice, all generated on an inbred C57BL/6 background using C57BL/6-derived embryonic stem cells, has…”
MethodSelf-citationUnleashing the power of inhibitors of oncogenic kinases through BH3 mimetics
Cragg, M. S., Harris, C., Strasser, A., & Scott, C. L. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2615 · Cited by 185
Self-citationBlack, M. E., Kokoris, M. S., & Sabo, P. J. (2001) · PubMed · Cited by 153
Labi, V., Erlacher, M., Kiessling, S., Manzl, C., Frenzel, A., O'Reilly, L., Strasser, A., & Villunger, A. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071658 · Cited by 123 · cited 3×
“…the proapoptotic activity of Bim, as tumors from GCV-treated mice lacking the BH3-only protein Bmf, which like Bim has been implicated in the apoptosis induced in certain cell types by growth factor deprivation (Labi et al., 2008), exhibited numbers of viable ECs comparable with WT controls (Fig.”
MethodResultSelf-citationKokoris, M. S., & Black, M. E. (2002) · Protein Science · doi:10.1110/ps.2460102 · Cited by 108 · cited 3×
“…the proapoptotic activity of Bim, as tumors from GCV-treated mice lacking the BH3-only protein Bmf, which like Bim has been implicated in the apoptosis induced in certain cell types by growth factor deprivation (Labi et al., 2008), exhibited numbers of viable ECs comparable with WT controls (Fig.”
MethodResultElefanty, A. G., Begley, C. G., Metcalf, D., Barnett, L., Köntgen, F., & Robb, L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.20.11897 · Cited by 87 · cited 2×
“From 2 to 4 × 107 anti-CD31 antibody–stained cells (in 50 μl) were subjected to FACS-Gal analysis by hypotonic loading with 50 μl FDG (fluorescein di--galactopyranoside; Sigma-Aldrich) followed by FACS analysis (Elefanty et al., 1998).”
MethodPark, Y. W., Younes, M. N., Jasser, S. A., Yigitbasi, O. G., Zhou, G., Bucana, C. D., Bekele, B. N., & Myers, J. N. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1665 · Cited by 59 · cited 1×
“Diverse treatment modalities provoke EC apoptosis in solid tumors (Dhanabal et al., 1999; Park et al., 2005); thus, polymorphisms in genes that control EC apoptosis, such as BIM or its regulators, may affect the therapeutic responses of cancer patients.”
Background
Cited by
The BCL-2 protein family, BH3-mimetics and cancer therapy
Delbridge, A. R. D., & Strasser, A. (2015) · Cell Death & Differentiation · doi:10.1038/cdd.2015.50 · Cited by 531
Self-citationDeciphering the rules of programmed cell death to improve therapy of cancer and other diseases
Strasser, A., Cory, S., & Adams, J. M. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.307 · Cited by 532
Self-citationPutoczki, T. L., Thiem, S., Loving, A., Busuttil, R. A., Wilson, N. J., Ziegler, P. K., Nguyen, P. M., Preaudet, A., Farid, R., Edwards, K. M., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.06.017 · Cited by 421
“Incidentally, inhibition of IL-11 signaling increased expression of the pro-apoptotic protein BIM in a manner akin to that observed in response to therapeutic inhibition of the STAT3-target VEGF-A (Naik et al., 2011).”
Endothelial cell apoptosis in angiogenesis and vessel regression
Watson, E. L., Grant, Z. L., & Coultas, L. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2577-y · Cited by 153
“The importance of apoptosis to vessel regression in these cases is supported by studies showing that hyaloid regression [19–22], retinal vaso-obliteration [19], and the tumor growth-suppressing effects of VEGF-A neutralization [23] are all inhibited in mice lacking genes essential for apoptosis.”
Self-citationTumor Angiogenesis and Anti-angiogenic Therapy
Kubota, Y. (2012) · The Keio Journal of Medicine · doi:10.2302/kjm.61.47 · Cited by 128
Metadata
- Authors
- Naik, E., O'Reilly, L. A., Asselin-Labat, M.-L., Merino, D., Lin, A., Cook, M., Coultas, L., Bouillet, P., Adams, J. M., & Strasser, A.
- Affiliations
- The University of Melbourne (AU)
- The Walter and Eliza Hall Institute of Medical Research, Parkville, Melbourne, Victoria 3052, Australia 1
- Walter and Eliza Hall Institute of Medical Research (AU)
- Corresponding author
- Strasser, Andreas
- ORCID
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2011-06-06
- Volume
- 208
- Issue
- 7
- Pages
- 1351-1358
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC3135358
- OpenAlex
- W2163882639
- Cited by
- 31
- References
- 29
- Citations by year
- 2025: 1 · 2024: 2 · 2021: 2 · 2020: 2 · 2017: 4 · 2016: 2 · 2015: 2 · 2014: 5 · 2013: 3 · 2012: 6
- FWCI
- 2.08
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-sa
- Locations
- The Journal of Experimental Medicine (publishedVersion, cc-by-nc-sa)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by-nc-sa)
- Funders
- Leukemia and Lymphoma Society
- National Institutes of Health
- Genentech
- Medical Research Council (461221)
- National Health and Medical Research Council (461221, 516703, 461299)
- National Cancer Institute (R01CA043540, CA 43540)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
- Keywords
- building information modeling, endothelial cell apoptosis, tumor vasculature, tumor growth inhibition, BH3-only proteins, Bcl-2 family proteins, tumor angiogenesis, vascular regression, anticancer agents
- MeSH terms
- Bcl-2-Like Protein 11, Animals, Antineoplastic Agents, Melanoma, Experimental, Membrane Proteins, Mice, Inbred C57BL, Mice, Transgenic, Proto-Oncogene Proteins, Recombinant Proteins, Thymidine Kinase, Ganciclovir, Gene Expression, Apoptosis, Mice, Knockout, Carcinoma, Lewis Lung, Vascular Endothelial Growth Factor A, Endothelial Cells, Cell Line, Tumor, Apoptosis Regulatory Proteins, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.